Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer--Gynaecological Cancer Group).

P.O. Witteveen; J. van der Velden; I. Vergote; C. Guerra; C. Scarabeli; C. Coens; G. Demonty; N. Reed

Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer--Gynaecological Cancer Group).

Translated title of the contribution: Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer--Gynaecological Cancer Group).

P.O. Witteveen
, J. van der Velden
, I. Vergote
, C. Guerra
, C. Scarabeli
, C. Coens
, G. Demonty
, N. Reed

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer--Gynaecological Cancer Group).
Original language	Undefined/Unknown
Pages (from-to)	1511-1516
Number of pages	6
Journal	Annals of Oncology
Volume	20
Issue number	9
Publication status	Published - 2009

Cite this

Witteveen, P. O., van der Velden, J., Vergote, I., Guerra, C., Scarabeli, C., Coens, C., Demonty, G., & Reed, N. (2009). Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer--Gynaecological Cancer Group). Annals of Oncology, 20(9), 1511-1516.

Witteveen, P.O. ; van der Velden, J. ; Vergote, I. et al. / Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer--Gynaecological Cancer Group). In: Annals of Oncology. 2009 ; Vol. 20, No. 9. pp. 1511-1516.

@article{83c3ba782a4c43a9a98fb69c76633b9c,

title = "Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer--Gynaecological Cancer Group).",

author = "P.O. Witteveen and \{van der Velden\}, J. and I. Vergote and C. Guerra and C. Scarabeli and C. Coens and G. Demonty and N. Reed",

year = "2009",

language = "Undefined/Unknown",

volume = "20",

pages = "1511--1516",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Limited",

number = "9",

}

Witteveen, PO, van der Velden, J, Vergote, I, Guerra, C, Scarabeli, C, Coens, C, Demonty, G & Reed, N 2009, 'Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer--Gynaecological Cancer Group).', Annals of Oncology, vol. 20, no. 9, pp. 1511-1516.

Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer--Gynaecological Cancer Group). / Witteveen, P.O.; van der Velden, J.; Vergote, I. et al.
In: Annals of Oncology, Vol. 20, No. 9, 2009, p. 1511-1516.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer--Gynaecological Cancer Group).

AU - Witteveen, P.O.

AU - van der Velden, J.

AU - Vergote, I.

AU - Guerra, C.

AU - Scarabeli, C.

AU - Coens, C.

AU - Demonty, G.

AU - Reed, N.

PY - 2009

Y1 - 2009

M3 - Article

SN - 0923-7534

VL - 20

SP - 1511

EP - 1516

JO - Annals of Oncology

JF - Annals of Oncology

IS - 9

ER -

Witteveen PO, van der Velden J, Vergote I, Guerra C, Scarabeli C, Coens C et al. Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer--Gynaecological Cancer Group). Annals of Oncology. 2009;20(9):1511-1516.